Skip to main content

Web Exclusives

Original Research, Practice Management, Health Policy and Reform

A Retrospective Trend Analysis of Utilization, Spending, and Prices for Generic Statins in the US Medicaid Population, 1991-2022

Yiyu Chen, MS; Patricia R. Wigle, PharmD, PhD; Orson Austin, MD; Jeff Jianfei Guo, BPharm, PhD

Iwilfin FDA Approved for Adults and Pediatric Patients with High-Risk Neuroblastoma

Welireg Now FDA Approved for Patients with Advanced Renal Cell Carcinoma

Ogsiveo First Treatment FDA Approved for Desmoid Tumors

FDA Approvals, Gastroenterology

Keytruda Plus Chemotherapy Receives New FDA Approvals for Advanced Biliary Tract Cancer and 2 Forms of Advanced Gastroesophageal Junction Adenocarcinoma

Tibsovo FDA Approved for Patients With Relapsed Myelodysplastic Syndromes and IDH1 Mutation

FDA Approved Loqtorzi, a PD-1 Inhibitor, for the Treatment of Adults With Metastatic or Recurrent Nasopharyngeal Carcinoma

Fruzaqla FDA Approved for Refractory Metastatic Colorectal Cancer

Rozlytrek Now Approved for Pediatric Patients Older Than 1 Month With Solid Tumors and NTRK Gene Fusion and in New Oral Pellet Form

FDA Authorizes Updated COVID-19 Vaccine Formulations for Better Protection Against Current Variants

Page 3 of 37
Results 21 - 30 of 364